ATROPINE SULFATE INJ 0.3MG/ML 0.3 MG
ATROPINE SULFATE : 0.3 MG · DIN 00497223 · HOSPIRA HEALTHCARE ULC
Health Canada status: CANCELLED POST MARKET
What is ATROPINE SULFATE INJ 0.3MG/ML?
ATROPINE SULFATE INJ 0.3MG/ML 0.3 MG contains ATROPINE SULFATE : 0.3 MG. It is listed in the Health Canada Drug Product Database under DIN 00497223, held by HOSPIRA HEALTHCARE ULC, supplied as SOLUTION for INTRAMUSCULAR ; INTRAVENOUS ; SUBCUTANEOUS administration. Health Canada currently lists it as cancelled post market, status dated 03-Aug-2012. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Product details and regulatory record
| DIN | 00497223 |
|---|---|
| Brand name | ATROPINE SULFATE INJ 0.3MG/ML |
| Generic / active ingredient | ATROPINE SULFATE : 0.3 MG |
| Manufacturer | HOSPIRA HEALTHCARE ULC |
| Strength | 0.3 MG |
| Dosage form | SOLUTION |
| Route of administration | INTRAMUSCULAR ; INTRAVENOUS ; SUBCUTANEOUS |
| Schedule | Prescription |
| ATC code | A03BA01 ATROPINE |
| Biosimilar | No |
| Health Canada status | CANCELLED POST MARKET |
| Status date | 03-Aug-2012 |
Is ATROPINE in shortage in Canada?
A Canadian shortage report is on file for a product containing this molecule: Resolved — reported by PFIZER CANADA ULC, last seen 20 Apr 2026. A shortage on one presentation does not always affect every DIN of the molecule — the alternatives below list what else is marketed in Canada. Nexara can confirm current availability and identify substitutions or import options where permitted.
What can be used instead?
Other Canadian products sharing ATC code A03BA01 ATROPINE. 6 of 19 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| ATROPINE INJECTION BP | 0.4 MG | SOLUTION | HIKMA CANADA LIMITED | MARKETED | DIN 02432188 |
| ATROPINE INJECTION BP | 0.6 MG | SOLUTION | HIKMA CANADA LIMITED | MARKETED | DIN 02432196 |
| ATROPINE SULFATE INJECTION | 0.5 MG / 5 ML | Solution | LABORATOIRE AGUETTANT | MARKETED | DIN 02426269 |
| ATROPINE SULFATE INJECTION | 1 MG / 5 ML | SOLUTION | LABORATOIRE AGUETTANT | MARKETED | DIN 02426277 |
| ATROPINE SULFATE INJECTION USP | .6 MG | SOLUTION | SANDOZ CANADA INCORPORATED | MARKETED | DIN 00392693 |
| ATROPINE SULFATE INJECTION USP | 0.4 MG | SOLUTION | SANDOZ CANADA INCORPORATED | MARKETED | DIN 00392782 |
| ATROPINE INJECTION BP 0.4MG/ML | 0.4 MG | SOLUTION | ALVEDA PHARMACEUTICALS INC | CANCELLED (UNRETURNED ANNUAL) | DIN 02094681 |
| ATROPINE INJECTION BP 0.6MG/ML | 0.6 MG | SOLUTION | ALVEDA PHARMACEUTICALS INC | CANCELLED (UNRETURNED ANNUAL) | DIN 02094703 |
| ATROPINE SULFATE INJ 0.1MG/ML | .1 MG | LIQUID | INTERNATIONAL MEDICATION SYSTEMS LTD. | CANCELLED POST MARKET | DIN 00243515 |
| ATROPINE SULFATE INJ 0.4MG/0.5ML | 0.8 MG | SOLUTION | INTERNATIONAL MEDICATION SYSTEMS LTD. | CANCELLED POST MARKET | DIN 00243523 |
Who else supplies ATROPINE worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. ATROPINE appears in 1388 registered pack listings across 11 markets, published on 9 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
Can this still be bought in Canada?
No. This Drug Identification Number is cancelled post market in Health Canada's Drug Product Database, so the product is no longer authorized for sale in Canada and Nexara does not supply it. This page is kept as a regulatory record.
If you are looking for a current equivalent, the alternatives above list every product sharing this therapeutic class, with the marketed ones first. Ask us to source an alternative
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.